Android app Apple app link

Genmab A/S (GMAB) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$18.66

south_east
-$0.92 (-4.7%)
Day's range
$18.62
Day's range
$19.1

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
03/11/2025 Truist Financial Asthika Goonewardene $45.00 $20.26   122.11%
09/03/2024 Morgan Stanley Vikram Purohit $31.00 $27.41   13.1%
08/09/2024 BMO Capital Etzer Darout $46.00 $27.07   69.93%
06/27/2024 BTIG Kaveri Pohlman $47.00 $25.67   83.09%
06/27/2024 H.C. Wainwright Raghuram Selvaraju $50.00 $25.71   94.48%
06/04/2024 Truist Financial Asthika Goonewardene $53.00 $28.83   83.84%
02/23/2024 BMO Capital Etzer Darout $48.00 $29.16   64.61%
11/28/2022 Morgan Stanley Matthew Harrison $34.00 $44.83   -24.16%

Genmab A/S FAQ's

Genmab A/S has been rated by research analysts at Truist Financial, Morgan Stanley, BMO Capital, BTIG, H.C. Wainwright, Leerink Partners in the past 90 days.

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.